BIM 23A760

DRUG2 trials

Sponsors

Ipsen

Conditions

AcromegalyCarcinoid Syndrome

Phase 2

Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly

TerminatedNCT00994214

IpsenAcromegaly

Start: 2009-10-31End: 2011-02-28Updated: 2019-11-22

Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome

TerminatedNCT01018953

IpsenCarcinoid Syndrome

Start: 2010-02-28End: 2011-01-31Updated: 2020-11-20